The notices it replaced
- Reissues: PA-19-273 PHS 2019-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required
- 2 steps back: PA-18-573 PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)
Replaced by PA-21-260.
Who won it before
231 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $142,490,113 in first-year total cost, median $548,182.
Most frequent study sections
- Special Emphasis Panel[ZRG1 RPHB-Y (12)]39
- Special Emphasis Panel[ZRG1 RPHB-Z (10)]36
- Special Emphasis Panel[ZRG1 RPHB-D (16)]12
- Special Emphasis Panel[ZRG1 SBIB-Y (12)]9
- Special Emphasis Panel[ZRG1 ETTN-C (10)]8
Most frequent institutions
- OREGON RES BEHAVIORAL INTERVENTION STRAT10
- MINNESOTA HEALTHSOLUTIONS CORPORATION8
- FLINT REHABILITATION DEVICES5
- ISA ASSOCIATES, INC.4
- ONCOIMMUNE, INC.4
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2022 | Nezavist a Novel Molecule for Treatment of Alcohol Use Disorder2R44AA024905-06 | TABAKOFF, BORIS | LOHOCLA RESEARCH CORPORATION, CO | $1,710,532 | ZRG1 |
| 2022 | IND‐enabling development of MM‐008 IVR, an antibody-based nonhormonal contraceptive intravaginal ring1R44HD107824-01 | CONE, RICHARD | MUCOMMUNE, LLC, NC | $1,039,122 | ZRG1 |
| 2022 | Evaluation of the safety and efficacy of non-invasive sonodynamic therapy for diffuse intrinsic pontine glioma1R44CA261516-01A1 | MARCUS, STUART | SONALASENSE INC, CA | $938,955 | ZRG1 |
| 2022 | Technology Assisted Treatment for Trichotillomania2R44MH114773-03 | FLESSNER, CHRISTOPHER A.KUMAR, SAMEER | HABITAWARE, INC., MN | $879,144 | ZRG1 |
| 2022 | Modular Convertible Child Safety Seat to Improve Usage2R44HD096963-02A1 | RYDBERG, NICK | MINNESOTA HEALTHSOLUTIONS CORPORATION, MN | $848,654 | ZRG1 |
| 2022 | Step UP for STEM and Health Careers: An Intervention to Reduce STEM-related biases and improve high school STEM learning environments2R44HD103517-02 | GILLIAM, MELISSA L.HOLL, JANE LOUISEPARSONS, TIMOTHY | RESILIENT GAMES STUDIO, LLC, IL | $834,357 | ZRG1 |
| 2022 | SonoHeal: Smart Resonating Closed-loop Airway Clearance Technology2R44HL152912-02A1 | BISWAS, RAJOSHI | COGNITA LABS, LLC, CA | $780,162 | ZRG1 |
| 2022 | Remote STATE training for Insomnia in Older Adults1R44AG076304-01 | VANVLEET, THOMAS | POSIT SCIENCE CORPORATION, CA | $534,429 | ZRG1 |
| 2022 | A Mobile Text Approach to Measurement and Feedback for Wraparound Care Coordination1R43MH126793-01A1 | BRUNS, ERIC J.DEROSIER, MELISSA E. | 3-C INSTITUTE FOR SOCIAL DEVELOPMENT, NC | $328,220 | ZRG1 |
| 2022 | Clinical study of a wearable therapeutic ultrasound sleeve for treatment of neuro-ischemic and ischemic diabetic foot ulcers1R43DK131707-01 | ELSTAD, JULIANA | VIBRATO MEDICAL, INC., CA | $300,000 | ZRG1 |
| 2022 | Improving physical function and quality of life in older adults with prediabetes utilizing interactive small-group resistance training through video conference technology1R44AG076087-01 | LEVITAN, ERICSTARR, KATHRYN N | IMPACTIV, INC., GA | $300,000 | ZRG1 |
| 2022 | Novel Myofunctional Therapy Water Bottle to Reduce Obstructive Sleep Apnea and Snoring1R43HL160368-01A1 | OLMANSON, ANDERS | REMASTERED SLEEP LLC, MN | $293,675 | ZRG1 |
| 2022 | Improving high-risk infant care: from Hospital to Home with Neoneur Telehealth1R44NR020275-01 | HOEDEMAKER, CAROLINE | NEONEUR LLC, NJ | $256,579 | ZRG1 |
| 2022 | A comprehensive web-based program to help advanced cancer patients plan for end of life1R44NR020341-01 | GOOD, JENNIFERSHEN, MEGAN JOHNSON | PEACEFULLY, INC., CA | $256,065 | ZRG1 |
| 2022 | Civamide Nasal Spray for the Treatment of Dry Eye1R43EY033606-01 | PHILLIPS, SCOTT | ELORAC, INC., IL | $160,284 | ZRG1 |
| 2021 | Using Clinical Treatment Data in a Machine Learning Approach for Sepsis Detection2R44AA030000-02 | HOFFMAN, JANA | DASCENA, INC., CA | $1,999,554 | ZRG1 |
| 2021 | Clinical Trial and Commercialization of a Wearable Therapeutic Ultrasound Device for Peripheral Arterial Disease1R44HL156543-01 · under PA-19-273 | DAW, DEREK | VIBRATO MEDICAL, INC., CA | $1,500,000 | ZRG1 |
| 2021 | Novel α2-Antiplasmin Inactivation for Lysis of Intravascular Thrombi (NAIL-IT) Trial1R44HL158376-01 | JEONG, SUN YONGREED, GUY LTAPSON, VICTOR F. | TRANSLATIONAL SCIENCES, INC., AZ | $1,408,991 | ZRG1 |
| 2021 | Assessing the safety and efficacy of SQ3370 in a phase 1b dose-expansion cohort at the recommended Phase 2 dose in patients with advanced sarcoma1R44CA265665-01 | MEJIA ONETO, JOSE M | SHASQI, INC., CA | $1,376,786 | ZRG1 |
| 2021 | A first in human clinical study of TT101, a synthetic immunomodulatory material to build new functional tissue over exposed bone as a one time treatment for diabetic limb preservation patients1R44DK130778-01 | DESHAYES, STEPHANIE | TEMPO THERAPEUTICS, INC., CA | $1,368,090 | ZRG1 |
| 2021 | Immune Biomarker Assessment and Manufacturing Development for SQ3370-001, a first-in-human phase I dose-escalation clinical trial to test a novel treatment against advanced solid tumors1R44CA261573-01 | MEJIA ONETO, JOSE M | SHASQI, INC., CA | $1,198,848 | ZRG1 |
| 2021 | Manganese Based MRI Contrast Agent - First In Human Clinical Trial1R44CA268392-01 | HOFFMAN, VERA | REVEAL PHARMA, MA | $1,149,940 | ZRG1 |
| 2021 | Clinical investigation of topical delivery of a muscarinic receptor antagonist for the prevention of chemotherapy-induced peripheral neuropathy1R44CA265565-01 | HANSEN, ANGELA | WINSANTOR, INC., CA | $1,101,366 | ZRG1 |
| 2021 | Clinical Evaluation of a Personalized Vaccine Immunotherapy in Combination with Checkpoint Inhibitors for Triple Negative Breast Cancer1R44CA257278-01A1 | PACK, CHRISTOPHER D | METACLIPSE THERAPEUTICS CORPORATION, GA | $1,061,403 | ZRG1 |
| 2021 | Randomized phase II study of TheraBionic in advanced hepatocellular carcinoma1R44CA256984-01A1 | PASCHE, VALERIE | THERABIONIC INC., NC | $1,059,091 | ZRG1 |
| 2021 | QBS10072S for the Treatment of Brain Metastatic Triple-Negative Breast Cancer1R44CA257579-01A1 | RINGOLD, GORDON M | QUADRIGA BIOSCIENCES, INC., CA | $1,053,136 | ZRG1 |
| 2021 | Patient tailored near real-time image-based treatment for interstitial PDT of Inoperable Cancer with Airway Obstruction - Phase IIa1R44CA265656-01 | POTASEK, MARYSHAFIRSTEIN, GAL | SIMPHOTEK, INC., NJ | $1,050,000 | ZRG1 |
| 2021 | Clinical Feasibility of Wireless Catheter-Free Urodynamics for Extended, Comprehensive Urological Evaluation in the Home Setting1R44DK131700-01 | HERRERA, DEREK | BRIGHT URO, INC., CA | $999,992 | ZRG1 |
| 2021 | A Phase 1, Open Label, Multicenter Trial to Assess the Safety, Tolerability and Efficacy of MB-106 in Patients with Relapsed or Refractory CD20+ B-Cell NHL or CLL1R44CA265616-01 | LITCHMAN, MANUEL | MUSTANG BIO, INC., MA | $999,336 | ZRG1 |
| 2021 | Phase 1/2a Clinical Study of Descartes-30 in Acute Respiratory Distress Syndrome1R44HL158446-01 | STEWART, CHARLES ANDREW | CARTESIAN THERAPEUTICS, INC., MD | $998,742 | ZRG1 |
| 2021 | Transformation of Dormant Spinal Networks to Mitigate Symptoms of Neurogenic Bladder1R44DK129164-01A1 | GAD, PARAG | SPINEX, INC., CA | $956,407 | ZRG1 |
| 2021 | Electrical stimulation to reduce pain and improve function after knee replacement2R44AG052196-04A1 | BOGGS, JOSEPH WILDER | SPR THERAPEUTICS, LLC, OH | $954,397 | ZRG1 |
| 2021 | IndieTrainer: Enabling Children with Cerebral Palsy to Receive Gamified Power Mobility Training in their Own Manual Wheelchairs1R44HD103522-01A1 | ZONDERVAN, DANIEL | FLINT REHABILITATION DEVICES, CA | $954,242 | ZRG1 |
| 2021 | Soft Spring Continence Pessary for Women1R44HD105574-01 | GAUPP, CHRISTINAROBERTS, MELODY ANN | LIV LABS INC., IL | $951,491 | ZRG1 |
| 2021 | Zip-stitch for Laparoscopic Hysterectomy - Clinical Validation1R44HD104539-01A1 | MAZZUCCO, DAN C | ZSX MEDICAL, LLC, PA | $928,014 | ZRG1 |
| 2021 | Non-Invasive Neuromodulation Device for the Treatment of Alcohol Use Disorder2R44AA027188-02 | BATKI, STEVEN LBURNETT, DANIEL ROGERS | THERANOVA, LLC, CA | $910,489 | ZRG1 |
| 2021 | Fostering Caregiver Connections via Intentional Technology Pairing for Caregivers of Patients with Alzheimer's Disease and Other Types of Dementia2R44AG065088-02 | KRAMER, KEVIN M. | MINNESOTA HEALTHSOLUTIONS CORPORATION, MN | $909,966 | ZRG1 |
| 2021 | Assistive ExoSkeleton and ExoTendon System for Increased Return of Limb Function after Diabetic Foot Ulcer1R44NR019969-01 | ROSER, MARK C | RESULTS GROUP, CT | $870,416 | ZRG1 |
| 2021 | Boost: A pragmatic inpatient rehabilitation strategy for improving musculoskeletal arm recovery after stroke1R44HD106850-01 | ZONDERVAN, DANIEL | FLINT REHABILITATION DEVICES, CA | $868,802 | ZRG1 |
| 2021 | DreamPort-Eclipse: Compact, ultra-low contact, custom fit CPAP human interface solution for obstructive sleep apnea1R44HL158286-01A1 | HEATHERINGTON, STUART | BLEEP, LLC, NC | $860,622 | ZRG1 |
| 2021 | Safety-Enhancing Motor Vehicle Child Safety Seat2R44CE003388-02 | RYDBERG, NICK | MINNESOTA HEALTHSOLUTIONS CORPORATION, MN | $846,699 | ZRG1 |
| 2021 | Socializing a Science-based Digital Therapeutic for Substance Use Disorders2R44DA047150-02 | GRABINSKI, MICHAEL JOHN | SQUARE2 SYSTEMS, INC., NH | $836,571 | ZRG1 |
| 2021 | Utility of Esophageal Cooling Therapy for the Prevention of Thermal Injury During Atrial Fibrillation1R44HL158375-01 | KULSTAD, ERIK BENJAMINSANTANGELI, PASQUALETSCHABRUNN, CORY MICHAEL | ADVANCED COOLING THERAPY, LLC, IL | $800,000 | ZRG1 |
| 2021 | An Open-Label, Multicenter, Phase 2/3 Efficacy and Safety Study of a targeted radiotherapy in Patients with Relapsed or Refractory Waldenstroms Macroglobulinemia1R44CA265558-01 | FRIEND, JOHNLONGCOR, JARROD | CELLECTAR BIOSCIENCES, INC., NJ | $763,080 | ZRG1 |
| 2021 | RT Assistant - handheld patient safety tool for mechanical ventilation2R44HL146012-02A1 | EULIANO, NEIL R. | CONVERGENT ENGINEERING, INC., FL | $756,143 | ZRG1 |
| 2021 | Ambient light activatable opsin based therapy for age-related macular degeneration2R44EY025905-04 | MOHANTY, SAMARENDRA KUMAR | NANOSCOPE TECHNOLOGIES, LLC, TX | $749,517 | ZRG1 |
| 2021 | A Video-Based mHealth Program to Support People Living with HIV Across the HIV Care Continuum2R44MD013644-02 · under PA-19-273 | MONTOYA, JORGE ALEJANDRO | SENTIENT RESEARCH, INC., CA | $744,090 | ZRG1 |
| 2021 | Reducing Colorectal Cancer Health Disparities: An mHealth Intervention to Improve Screening among African American Men2R44CA246899-02A1 | LEAF, SAMANTHA L. | ISA ASSOCIATES, INC., VA | $723,593 | ZRG1 |
| 2021 | Device to Deliver Intra-Operative Therapeutic Hypothermia for Hearing Preservation in Cochlear Implantation1R44DC019586-01 | KING, CURTIS SCOTTRAJGURU, SUHRUD M. | RESTOREAR DEVICES, LLC, MT | $712,765 | ZRG1 |
| 2021 | Strengthening Families Program Online for Teens and Families2R44DA046238-02A1 · under PA-19-273 | KUMPFER, KAROL L. | STRENGTHENING FAMILIES PROGRAM, LLC, UT | $682,065 | ZRG1 |
| 2021 | Technology-based Training Tool for an Empirically-Supported Group-Based HIV and STI Prevention Intervention for Juvenile Offenders2R44MD014113-02 | DONENBERG, GERI RFEIL, EDWARD GUSTAVSMITH, DAVID RANDOLPH | OREGON RES BEHAVIORAL INTERVENTION STRAT, OR | $675,605 | ZRG1 |
| 2021 | Assist-Knee: Energy Harvesting for Sit-to-Stand-to-Sit Transitions2R44HD097826-02A1 | CHANG, SARAH | ORTHOCARE INNOVATIONS, LLC, WA | $665,414 | ZRG1 |
| 2021 | Diabetes Prevention for Hispanics Residing in Rural Communities: A Mobile Web-based Approach2R44MD014082-02A1 | RIOS, DEBRA | ISA ASSOCIATES, INC., VA | $661,086 | ZRG1 |
| 2021 | Interactive Training Tool Providing Technique Feedback for COPD Medication Delivery1R44AG071430-01 · under PA-19-273 | LICHTER, PATRICK | KORONIS BIOMEDICAL TECHNOLOGIES CORPORAT, MN | $618,070 | ZRG1 |
| 2021 | Clinical Feasibility Study of a Novel Flexible, Non-occlusive GERD Treatment Device1R44DK127882-01A1 | TIHON, CLAUDE NMN | APLOS MEDICAL INC, MN | $596,460 | ZRG1 |
| 2021 | SkillTalk: Communication Training around Sexual Health Topics for Parents of Youth with Autism Spectrum Disorder2R44HD097906-02A1 | FIRPO-TRIPLETT, REGINA | DFUSION, INC., CA | $587,743 | ZRG1 |
| 2021 | Kidney Support in Pediatric Patients Using an Ultrafiltration Device1R44DK127631-01A1 | KNUESEL, ROBERT J | KORONIS BIOMEDICAL TECHNOLOGIES CORPORAT, MN | $567,212 | ZRG1 |
| 2021 | Targeted alpha-emitter therapy of patients with PRRT refractory neuroendocrine tumors1R44CA265421-01 | TWOROWSKA, IZABELA | RADIOMEDIX, INC., TX | $548,182 | ZRG1 |
| 2021 | Disease Modifying Treatment for Hemolytic Disorders1R44HL156774-01A1 | BANSAL, REKHA | NOVELMED THERAPEUTICS, INC., OH | $533,165 | ZRG1 |
| 2021 | Intestinal Lengthening via Distraction Enterogenesis for the Treatment of Short Bowel Syndrome1R44DK127658-01A1 | BESSETTE, ANDRE | ECLIPSE ENTEROGENESIS, INC., CA | $423,221 | ZRG1 |
| 2021 | Furthering the clinical development of a first in class, water resistant sunscreen to meet emerging environmental regulations1R43CA257692-01A1 | ISAACMAN, STEVEN | NANOMETICS, LLC, CA | $398,768 | ZRG1 |
| 2021 | Treating Drivers of Suicide in Primary Care using Jaspr Health1R44AA029868-01 | DIMEFF, LINDA AJOBES, DAVID ALAN | EVIDENCE-BASED PRACTICE INSTITUTE, INC., WA | $397,990 | ZRG1 |
| 2021 | Personal relevance of psychotherapy for Asian Americans: A mHealth problem-solving intervention to reduce stress (PRoP-AA)1R44MH125698-01A1 | HALL, GORDON C. NAGAYAMAMONROE, TERRIEWENDT, ADAM JOHN | IRIS MEDIA, INC., OR | $381,931 | ZRG1 |
| 2021 | FHIR-ed Up for Tobacco Cessation1R43HL156588-01A1 · under PA-19-273 | JOHNSON, SARA S | PRO-CHANGE BEHAVIOR SYSTEMS, INC., RI | $378,553 | ZRG1 |
| 2021 | Facilitating supervised self-management of stimulant medications among adolescents: improving adherence, reducing stigma, and supporting caregivers1R43DA053121-01A1 | PERSE, ARTIN | PILLSMART INC., NY | $324,072 | ZRG1 |
| 2021 | A Digital Therapeutic for Pain Relief through AI-Guided Visual Stimulation1R43DA054845-01 | HANINA, ADAM | DANDELION SCIENCE CORP, NY | $319,489 | ZRG1 |
| 2021 | WayToServe Plus: In-service Professional Development Component to Improve Responsible Alcohol Service1R44AA029364-01 | BULLER, DAVID BWOODALL, W GILL | KLEIN BUENDEL, INC., CO | $314,423 | ZRG1 |
| 2021 | Additive Manufacturing of Patient-Specific Masks and Nasal Prongs to Improve Pediatric Ventilation Outcomes and Reduce Pressure Sores1R44HD105552-01 | BAGWELL, ROGER BROOKS | ACTUATED MEDICAL, INC., PA | $309,518 | ZRG1 |
| 2021 | Demonstration of a Digital Care Program for Methamphetamine Use Disorder1R43DA055394-01 | MUHLNER, KRISTIN | AFFECT THERAPEUTICS, INC., NY | $309,360 | ZRG1 |
| 2021 | Empower Neuromodulation System, a home-use device for the treatment of anxiety disorders1R43AT011497-01 | BURNETT, DANIEL ROGERS | THERANOVA, LLC, CA | $302,951 | ZRG1 |
| 2021 | Novel On Demand Female Oral Contraceptive1R43HD104508-01 · under PA-19-273 | ARCHER, DAVID FITZGERALD | INNOVAGYN, INC., VA | $300,001 | ZRG1 |
| 2021 | Reducing time to heal chronic leg wounds through monitoring, engagement and intelligent intervention via WoundAlert system1R43AG074834-01 | ENGEL, JONATHAN M | SURAMEDICAL, LLC, MN | $299,977 | ZRG1 |
| 2021 | A Fully Remote Telehealth Brain Computer Interface And Assessment System For Motor Rehabilitation Of Chronic Stroke1R44HD105579-01 | BHUGRA, KERN | NEUROLUTIONS, INC, CA | $299,891 | ZRG1 |
| 2021 | Toward development of a comprehensive, in-home, active seating system to lessen sedentariness and improve health and wellness in older adults.1R43AG074697-01 | LEIB, ROGERNIEMIEC, STACEY LYNN SCHEPENS | ACTIV SITTING, INC., CA | $291,700 | ZRG1 |
| 2021 | SSW Works: A Virtual Learning Environment for Occupational Skin Cancer Prevention1R44CA257778-01A1 | BULLER, MARY K | KLEIN BUENDEL, INC., CO | $263,012 | ZRG1 |
| 2021 | A Novel Device for Training and Evaluating Ultrasound-Guided Procedures In Anesthesia1R43GM144333-01 | RAJAN, PURNIMA | CLEAR GUIDE MEDICAL, INC., MD | $259,613 | ZRG1 |
| 2021 | Development of a telehealth medication-assisted treatment (MAT) system for patients with opioid use disorder (OUD)1R43CE003533-01 | ROSLYAKOV, STANISLAV | ADDINEX TECHNOLOGIES, INC., NY | $259,559 | ZRG1 |
| 2021 | Developing the Unified Protocol-Single Session Experience Platform for Adolescent Mental Health1R43MH128075-01 | DEROSIER, MELISSA E.EHRENREICH-MAY, JILLSCHLEIDER, JESSICA LEE | 3-C INSTITUTE FOR SOCIAL DEVELOPMENT, NC | $259,291 | ZRG1 |
| 2021 | Interactive Digital Media-based Learning for Hand Hygiene in School-Age Children1R43GM144007-01 | CRILEY, JASMINKA | INDELIBLE LEARNING, INC., CA | $256,579 | ZRG1 |
| 2021 | Walk with Me (WWM) for Perinatal Grief1R43MH126788-01A1 | CIOFFI, CAMILLE CSCHWEER-COLLINS, MARIASMITH, DAVID RANDOLPH | OREGON RES BEHAVIORAL INTERVENTION STRAT, OR | $256,501 | ZRG1 |
| 2021 | Digital health for medication adherence among African Americans with hypertension1R43MD015969-01A1 | WEITZMAN, PATRICIA FLYNN | ENVIRONMENT AND HEALTH GROUP, INC., MA | $256,460 | ZRG1 |
| 2021 | Integrated Smart Speaker/Mobile Application to Promote Positive Parenting Among Caregivers of Youth with Challenging Behaviors1R43MH124577-01A1 | FEIL, EDWARD GUSTAVMETZLER, CAROL WSMITH, DAVID RANDOLPH | OREGON RES BEHAVIORAL INTERVENTION STRAT, OR | $256,429 | ZRG1 |
| 2021 | Novel Pediatric Endotracheal Tube Securement System1R44HD103566-01A1 | RYDBERG, NICK | MINNESOTA HEALTHSOLUTIONS CORPORATION, MN | $256,216 | ZRG1 |
| 2021 | Remote Digital Health Intervention to Improve Balance and Reduce Fall Risk1R43AG074833-01 | VANVLEET, THOMAS | POSIT SCIENCE CORPORATION, CA | $254,947 | ZRG1 |
| 2021 | FitMi PD: an affordable home therapy device for individuals with Parkinson's disease1R43AG071253-01 · under PA-19-273 | RUSSELL, IAN MILES | FLINT REHABILITATION DEVICES, CA | $252,132 | ZRG1 |
| 2021 | Point of Care Lung CT for Patients with Acute Respiratory Failure1R44HL158452-01 | VANKAMPEN, WILLIAM CHARLES | XORAN TECHNOLOGIES, LLC, MI | $252,124 | ZRG1 |
| 2021 | An online professional development course to train CHWs to provide oral health outreach to low-income Black guardians1R43MD016352-01 | COOPER, DEXTER L | KDH RESEARCH AND COMMUNICATION, INC., GA | $251,032 | ZRG1 |
| 2021 | Natural Sleep Endoscopy system for obstructive sleep apnea: improving the measurement of pattern of airway obstruction and treatment outcomes1R43HL154958-01A1 · under PA-19-273 | KEZIRIAN, ERIC JAMES | BERENDO SCIENTIFIC, LLC, CA | $246,784 | ZRG1 |
| 2021 | NON-INVASIVE WRIST-WATCH DEVICE FOR REMOTE MONITORING OF HEART FAILURE PATIENTS1R43HL156691-01A1 | MERCHANT, MARIA | INCARDIA INC., CA | $224,700 | ZRG1 |
| 2021 | Increasing Health Equity Through In-The-Moment Reading Assistance for Adults with Diabetes Served at Community Health Centers1R43NR020340-01 | SHIPPEE, NATHAN DZIMMERMAN-BENCE, NED | GOGYUP, INC., MN | $200,000 | ZRG1 |
| 2020 | Noninvasive multiphoton imaging of subcellular structures with color contrast for rapid detection of skin cancers2R44CA221591-02A1 · under PA-18-573 | SANCHEZ, GABRIEL NESTOR | ENSPECTRA HEALTH, INC., CA | $1,944,985 | ZRG1 |
| 2020 | Novel Therapy System for Atrial Fibrillation1R44HL154937-01 · under PA-19-273 | BOURN, DAVID W | CARDIALEN, INC., MO | $1,605,396 | ZRG1 |
| 2020 | Daily & Localized NSAID Sonophoresis for Symptomatic Treatment of Knee Osteoarthritis2R44AG061985-03 · under PA-19-273 | LEWIS, GEORGE KENNETH | ZETROZ SYSTEMS, LLC, CT | $1,442,543 | ZRG1 |
| 2020 | Clinical performance of hemodynamics-based non-invasive device for skin cancer testing1R44CA250768-01 · under PA-19-273 | CHACHISVILIS, MIRIANAS | VERISKIN, INC., CA | $1,164,975 | ZRG1 |
| 2020 | Vibration-integrated Lancing System to Reduce Stress, Pain Response, Heel Damage and Developmental Harm from Recurring Heel Sticks in Neonates2R44HD088139-02A1 · under PA-19-273 | CLEMENT, RYAN S | ACTUATED MEDICAL, INC., PA | $1,136,037 | ZRG1 |
| 2020 | Non-clinical Combination Pharmacology Studies and Phase 1 Clinical Development of IO-202 in Acute Myeloid Leukemia (AML)1R44CA250543-01A1 · under PA-19-273 | LIAO, CHARLENE | IMMUNE-ONC THERAPEUTICS, INC., CA | $1,070,000 | ZRG1 |
| 2020 | Health in Motion- A Pragmatic Clinical Trial2R44AG043191-04A1 · under PA-19-273 | FLYNN, SHERYL | BLUE MARBLE REHAB, INC., CA | $1,014,720 | ZRG1 |
| 2020 | Randomized Prospective Trial of Breast Cancer Locator Guided vs. Wire Localized Partial Mastectomy for Breast Cancer1R44CA247124-01A1 · under PA-19-273 | KRISHNASWAMY, VENKATARAMANAN | CAIRNSURGICAL, INC., NH | $1,007,656 | ZRG1 |
| 2020 | Long-acting PTH for hypoparathyroidism2R44DK107231-04 · under PA-19-273 | HALES, LAURA M | EXTEND BIOSCIENCES, INC., MA | $1,000,000 | ZRG1 |
| 2020 | Novel Expandable Infusion Catheter for the Treatment of Acute Pulmonary Embolism1R44HL151032-01 · under PA-18-573 | FIRTH, BRIAN GARRIOCK | THROMBOLEX, INC., PA | $999,997 | ZRG1 |
| 2020 | A Bullet Proof vascular graft to prevent dialysis access cannulation injury2R44DK108488-04A1 · under PA-19-273 | KNIGHT, JOSEPH | INNAVASC MEDICAL, INC., NC | $999,841 | ZRG1 |
| 2020 | Non-surgical treatment option for pelvic organ prolapse2R44HD097809-02 · under PA-18-573 | HANISSIAN, PAUL | REIA, LLC, NH | $994,018 | ZRG1 |
| 2020 | Phase 1/2 Clinical Study of Humanized Anti-BCMA CAR T Cells in Relapsed/Refractory Multiple Myeloma (MM)2R44CA221432-02A1 · under PA-19-273 | STEWART, CHARLES ANDREW | CARTESIAN THERAPEUTICS, INC., MD | $988,226 | ZRG1 |
| 2020 | Development of 7HP349, an oral integrin activator to enhance therapeutic responses to immune checkpoint inhibitors1R44CA250646-01A1 · under PA-19-273 | LEWIS, LIONEL DAVIDMARATHI, UPENDRA | 7 HILLS PHARMA, LLC, TX | $984,409 | ZRG1 |
| 2020 | Automating and Obtaining FDA Approval for a Digital Intervention for Depression2R44MH113520-03 · under PA-19-273 | FRANK, ELLEN | HEALTH RHYTHMS, INC., NY | $974,672 | ZRG1 |
| 2020 | Talk STEM Familia: Dual-Language Academic Vocabulary-Building Technology to Improve Educational, Career, and Health Outcomes Among Latinx Students2R44MD013619-02 · under PA-19-273 | MARQUEZ, JESSIEVADASY, PATRICIA F | OREGON RES BEHAVIORAL INTERVENTION STRAT, OR | $965,354 | ZRG1 |
| 2020 | Development of Ciclopirox Prodrug as a Novel Systemic Treatment for High-Risk Non-Muscle Invasive Bladder Cancer1R44CA246997-01A1 · under PA-19-273 | MC CULLOCH, WILLIAMWEIR, SCOTT JAMES | CICLOMED, LLC, MO | $936,240 | ZRG1 |
| 2020 | Phase 2 Clinical Trial Evaluating a Novel Therapy in Patients who are Post-lung Transplant1R44HL151144-01A1 · under PA-19-273 | COPELAND, DANIEL W.DURHAM, CAROLYN | RENOVION, INC., NC | $920,791 | ZRG1 |
| 2020 | The Use of Photobiomodulation (PBM) in the Treatment for Diabetic Macular Edema2R44EY025892-02A1 · under PA-19-273 | TEDFORD, CLARK E | LUMITHERA, INC., WA | $897,302 | ZRG1 |
| 2020 | Video-Based Microskills Training Intervention to Improve Health Education to Reduce Risk Behaviors in Youth1R44HD102288-01A1 · under PA-19-273 | FIRPO-TRIPLETT, REGINAKUHN, TAMARA J. | DFUSION, INC., CA | $885,147 | ZRG1 |
| 2020 | Assessing the impact of app-delivered lighting interventions on fatigue in three populations of cancer patients2R44CA236557-02A1 · under PA-19-273 | WALCH, OLIVIA | ARCASCOPE, INC, VA | $873,205 | ZRG1 |
| 2020 | Middle-ear reflex testing using wideband acoustic immittance2R44DC016780-02 · under PA-19-273 | HOOD, LINDA J.JENG, PATRICIA S | MIMOSA ACOUSTICS, IL | $866,153 | ZRG1 |
| 2020 | Novel, Non-Toxic Ocular Antiseptic For Intravitreal Injection Therapy1R44EY031206-01 · under PA-18-573 | CHALBERG, THOMAS WSMITH, STEPHEN J | IRENIX MEDICAL, INC., CA | $847,954 | ZRG1 |
| 2020 | Applying Technology-Enabled Contingency Management for Alcohol Use Disorder At Scale in a Medicaid Population2R44AA026234-02 · under PA-19-273 | GASTFRIEND, ERIC ELIAS | DYNAMICARE HEALTH, INC., MA | $828,764 | ZRG1 |
| 2020 | Nutritional Stimulation of Muscle Protein Synthesis and Metabolic Rate After Bariatric Surgery1R44DK125151-01 · under PA-19-273 | WOLFE, ROBERT R | AMINO COMPANY LLC, THE, DE | $806,481 | ZRG1 |
| 2020 | A Technology-Based Novel Functional Skills Assessment and Training Program for Adults with and without Cognitive Impairments. Develop the next generation software solution.2R44AG057238-03A1 · under PA-19-273 | KALLESTRUP, PETER | I-FUNCTION, INC., FL | $802,500 | ZRG1 |
| 2020 | Reducing Health Disparities among African American Women: A Mobile Cognitive Behavioral Stress Management Intervention2R44MD014077-02 · under PA-19-273 | BILLINGS, DOUGLAS W | ISA ASSOCIATES, INC., VA | $801,362 | ZRG1 |
| 2020 | Motivating Occupational Virtual Experiences In Therapy for kids2R44HD092169-02A1 · under PA-19-273 | ADAMS, RICHARD J. | BARRON ASSOCIATES, INC., VA | $777,739 | ZRG1 |
| 2020 | Percutaneous Ultrasound Gastrostomy: Clinical Evaluation of a Feeding Tube Placement Method in the Pediatric Population2R44DK123910-02A1 · under PA-19-273 | CAROLAN, HOWARD | COAPTECH, LLC, MD | $768,234 | ZRG1 |
| 2020 | A Novel Orogastric/Nasogastric Feeding Tube for Optimizing Nutritional Administration in the Neonatal Intensive Care Unit Population2R44HD098938-02A1 · under PA-19-273 | BURNETT, DANIEL ROGERS | THERANOVA, LLC, CA | $765,005 | ZRG1 |
| 2020 | Interactive Cognitive Behavioral Therapy for Insomnia2R44CA232905-02A1 · under PA-19-273 | AREM, HANNAHGREENBERG, DANIEL J | MEDIA REZ, LLC, DC | $756,832 | ZRG1 |
| 2020 | A ratcheting prosthetic partial finger using advanced rapid manufacturing technology2R44HD096942-02A1 · under PA-19-273 | SLIKER, LEVIN | POINT DESIGNS, LLC, CO | $749,508 | ZRG1 |
| 2020 | Multi-Media Parent-based Intervention to Promote Dental Hygiene Among Young Children: BeReady2Smile2R44DE027001-02A1 · under PA-18-573 | FEIL, EDWARD GUSTAVSMITH, DAVID RANDOLPH | OREGON RES BEHAVIORAL INTERVENTION STRAT, OR | $746,784 | ZRG1 |
| 2020 | Effects of the Next Generation TNF Inhibitor (XPro1595) on Inflammation-related Deficits in Reward Circuitry and Motivation in Depression1R44MH125480-01 · under PA-19-273 | BARNUM, CHRISTOPHER J | INMUNE BIO, INC., FL | $739,739 | ZRG1 |
| 2020 | An additive solution optimized for anaerobic (hypoxic) RBC storage to minimize storage lesion development.1R44HL149579-01A1 · under PA-18-573 | NEMKOV, TRAVISYOSHIDA, TATSURO | NEW HEALTH SCIENCES, INC., MA | $721,856 | ZRG1 |
| 2020 | A system and process to improve the satisfaction with hearing health products1R44DC019072-01A1 · under PA-19-273 | CONDON, JOHN PAUL | INNOVATIVE DESIGN LABS, INC., MN | $712,183 | ZRG1 |
| 2020 | A Phase 3 Multicenter, Randomized, Vehicle-Controlled Clinical Study to Evaluate the Safety and Efficacy of an Ophthalmic Emulsion of Nintedanib in Pterygium Patients2R44EY028784-04A1 · under PA-19-273 | YANG, RONG | CLOUDBREAK THERAPEUTICS, LLC, CA | $699,988 | ZRG1 |
| 2020 | Continuous wearable monitor for the detection and release of Freezing of Gait2R44AG057263-02 · under PA-19-273 | CONDON, JOHN PAUL | INNOVATIVE DESIGN LABS, INC., MN | $699,236 | ZRG1 |
| 2020 | Wearable Transcutaneous Electrical Acustimulation for Gastroparesis1R44AT011380-01A1 · under PA-19-273 | YIN, JIEYUN NONE | TRANSTIMULATION RESEARCH, INC., OK | $618,361 | ZRG1 |
| 2020 | Optimized Medial Olivocochlear Reflex Screening and Testing Module1R44DC018491-01A1 · under PA-19-273 | DELGADO, RAFAEL E | INTELLIGENT HEARING SYSTEMS, FL | $618,360 | ZRG1 |
| 2020 | A Model for Predicting 2-Year Risk of Incident Late Age-related Macular Degeneration1R44EY031202-01A1 · under PA-19-273 | BHUIYAN, ALAUDDIN | IHEALTHSCREEN, INC., NY | $585,067 | ZRG1 |
| 2020 | An intervention to increase HIV Testing Uptake among Adolescents and Young Adults2R44HD088332-02A1 · under PA-18-573 | CASTEL, AMANDA DERRYCKGREENBERG, DANIEL J | MEDIA REZ, LLC, DC | $540,743 | ZRG1 |
| 2020 | EMG Voice Restoration2R44DC017097-02 · under PA-19-273 | DE LUCA, GIANLUCA | ALTEC, INC., MA | $506,347 | ZRG1 |
| 2020 | Development of a stress kinase inhibitor therapeutic candidate for Alzheimer's Disease and related dementia1R44AG071388-01 · under PA-19-273 | ANDERSON, WAYNE FHONIG, LAWRENCE S | NEUROKINE THERAPEUTICS, LLC, NY | $500,000 | ZRG1 |
| 2020 | Mhealth for Pre-exposure Prophylaxis Adherence by Young Adult MSM2R44MH112221-02 · under PA-19-273 | WEITZMAN, PATRICIA FLYNN | ENVIRONMENT AND HEALTH GROUP, INC., MA | $498,759 | ZRG1 |
| 2020 | MyHealthyPregnancy mobile health app: Combining behavioral science and machine learning for risk communication during the peripartum period2R44DP006417-02 · under PA-19-273 | CASTILLO, ANABEL F | NAIMA HEALTH, LLC, PA | $497,952 | ZRG1 |
| 2020 | Phase II Clinical Trial of G207 HSV To Treat Children with High Grade Gliomas1R44CA250883-01 · under PA-19-273 | GILLESPIE, GEORGE YANCEY | TREOVIR, INC, AL | $497,320 | ZRG1 |
| 2020 | A novel non-invasive device for screening and optimized management to improve heart failure outcomes in patients with diabetes mellitus1R44HL149561-01A1 · under PA-19-273 | KALE, KAUSTUBH | AVENTUSOFT, LLC, FL | $400,000 | ZRG1 |
| 2020 | First in Human Phase I/II clinical trial of ONC-392: Preserving CTLA-4 immune tolerance checkpoint for safer and more effective cancer immunotherapy1R44CA250824-01 · under PA-19-273 | ROLFO, CHRISTIAN DIEGOZHENG, PAN | ONCOIMMUNE, INC., MD | $400,000 | ZRG1 |
| 2020 | Treatment of Glioblastoma: the combination of fluorescence guided surgery and photodynamic therapy1R44CA247127-01A1 · under PA-19-273 | POTTER, WILLIAM R | PHOTOLITEC, LLC, NY | $400,000 | ZRG1 |
| 2020 | PET imaging of radiation induced lung injury1R44CA250771-01 · under PA-19-273 | HUMBLET, VALERIE | COLLAGEN MEDICAL, LLC, MA | $399,990 | ZRG1 |
| 2020 | ClientBot: A conversational agent that supports skills practice and feedback for Motivational Interviewing for AUD1R44AA028463-01 · under PA-19-273 | ATKINS, DAVID CHARLES | LYSSN.IO, INC., WA | $397,456 | ZRG1 |
| 2020 | Cindi Study: A Phase II Clinical Trial to Combine CD24Fc with Ipilimumab and Nivolumab to Decrease Immune Related Adverse Events (irAE)1R44CA250889-01 · under PA-19-273 | HU-LIESKOVAN, SIWENZHENG, PAN | ONCOIMMUNE, INC., MD | $396,664 | ZRG1 |
| 2020 | Expanded Clinical Trial of Granulocyte Colony-Stimulating Factor (G-CSF) to Treat Hot Flush and Other Vasomotor Symptoms in Women with Naturally-Occurring and Surgically-Induced Menopause1R43AG066538-01 · under PA-18-573 | EMLEN, JAMES WOODRUFF | MENOGENIX, INC., CO | $299,831 | ZRG1 |
| 2020 | A novel intravaginal ring technology featuring the sustained release of natural progesterone for the prevention of preterm birth in at-risk women1R44HD101169-01A1 · under PA-19-273 | FRIEND, DAVID R | DARE BIOSCIENCE, INC., CA | $299,696 | ZRG1 |
| 2020 | Development of a robotic ankle assist device to improve mobility in individuals with movement disorders.1R44HD104328-01 · under PA-19-273 | BROWNING, RAYMOND CLIFTON | BIOMOTUM, LLC, OR | $298,438 | ZRG1 |
| 2020 | hANDY-i(TM): A non-invasive, dual-sensor handheld imager for intraoperative preservation of parathyroid glands1R43EB030874-01 · under PA-19-273 | CHA, RICHARD JAEPYEONGTUFANO, RALPH P | OPTOSURGICAL, LLC, DE | $252,131 | ZRG1 |
| 2020 | SleepFlexTM head and neck exercise program for the treatment of obstructive sleep apnea1R43HL154870-01 · under PA-19-273 | KEZIRIAN, ERIC JAMES | BERENDO SCIENTIFIC, LLC, CA | $252,113 | ZRG1 |
| 2020 | Development and evaluation of a high-fidelity newborn simulator for breastfeeding education of health professionals1R43HD103530-01 · under PA-19-273 | CHUISANO, SAMANTHA | LIQUIDGOLDCONCEPT, INC, CA | $252,035 | ZRG1 |
| 2020 | A Novel Distracted Driving Prevention Tool1R44HD103550-01 · under PA-19-273 | SEIFERT, SARA | MINNESOTA HEALTHSOLUTIONS CORPORATION, MN | $252,004 | ZRG1 |
| 2020 | Utilizing Smart Speaker Technology to Deliver Parenting Education Support to Parents of Young Children1R43HD101190-01A1 · under PA-19-273 | METZLER, CAROL WSMITH, DAVID RANDOLPH | OREGON RES BEHAVIORAL INTERVENTION STRAT, OR | $251,959 | ZRG1 |
| 2020 | Portable Noninvasive Positive Airway Device for COPD Patient Therapy1R44HL154932-01 · under PA-19-273 | KNUESEL, ROBERT J | KORONIS BIOMEDICAL TECHNOLOGIES CORPORAT, MN | $251,772 | ZRG1 |
| 2020 | Vascular CT contrast agent development1R44HL152877-01 · under PA-19-273 | DAVIS, MICHAEL A | NEXTRAST, INC., CA | $249,980 | ZRG1 |
| 2020 | Home biofeedback (VibroGait) for people with impaired somatosensation1R44AG071250-01A1 · under PA-19-273 | EL-GOHARY, MAHMOUDMANCINI, MARTINA | APDM, INC., OR | $249,149 | ZRG1 |
| 2020 | Speech Hero: a rhythm-based speech therapy app for individuals with aphasia1R43DC018771-01 · under PA-19-273 | RUSSELL, IAN MILES | FLINT REHABILITATION DEVICES, CA | $225,000 | ZRG1 |
| 2020 | Improved Systems for Respiratory Support1R44HL150926-01 · under PA-18-573 | RYDBERG, NICK | MINNESOTA HEALTHSOLUTIONS CORPORATION, MN | $224,923 | ZRG1 |
| 2020 | Video Assisted Speech Technology to enhance functional language abilities in individuals with Autism Spectrum Disorder1R43DC018447-01 · under PA-18-573 | BRADY, LOIS JEAN | ITHERAPY, CA | $224,789 | ZRG1 |
| 2020 | SIBTime: Media-enhanced Technology for Promoting the Behavioral Health and Family Relationships of Typically Developing Young Siblings1R43MD015947-01 · under PA-19-273 | MARQUEZ, JESSIEVADASY, PATRICIA F | OREGON RES BEHAVIORAL INTERVENTION STRAT, OR | $223,421 | ZRG1 |
| 2020 | Healthy Aging: an EEG-based wearable device to accurately monitor sleep and enhance quality for improved cognitive functioning1R43AG065104-01A1 · under PA-19-273 | SANTOSTASI, GIOVANNI | DEEPWAVE TECHNOLOGIES, INC., CA | $222,900 | ZRG1 |
| 2020 | GratePic mHealth App Feasibility Study1R43NR018622-01 · under PA-18-573 | ARRINGTON, CHRISTOPHER LAWSON | GRATEPIC, INC., AL | $219,569 | ZRG1 |
| 2020 | Web-based Resource for Children and Adolescents about Clinical Research1R44NR019565-01A1 · under PA-19-273 | PARKER, ALISON ELAINESCULL, TRACY MARIE | INNOVATION RESEARCH AND TRAINING, INC., NC | $206,644 | ZRG1 |
| 2019 | Risperidone Subcutaneous Implant2R44MH094036-04 · under PA-18-573 | MARTIN, FRANCIS JOSEPH | DELPOR, INC., CA | $4,037,027 | ZRG1 |
| 2019 | Clinical Evaluation of Photobiomodulation (PBM) in dry AMD Patients2R44EY025508-02 · under PA-18-573 | TEDFORD, CLARK E | LUMITHERA, INC., WA | $1,502,600 | ZRG1 |
| 2019 | Marijuana Breath Analyzer2R44DA041225-02 · under PA-18-573 | DWEIK, BADAWI M | GINER, INC., MA | $1,227,839 | ZRG1 |
| 2019 | A phase II dose expansion clinical trial testing the efficacy of CD24Fc for the prophylaxis of severe graft vs host disease and leukemia relapse1R44CA246991-01 · under PA-18-573 | DEVENPORT, MARTINLIU, YANGZHENG, PAN | ONCOIMMUNE, INC., MD | $1,014,321 | ZRG1 |
| 2019 | Antithrombotic Protein C Activator for Hemodialysis1R44HL147695-01 · under PA-18-573 | TUCKER, ERIK IANVERBOUT, NORAH | ARONORA, INC., OR | $994,097 | ZRG1 |
| 2019 | Phase 1 cross over biodistribution study of [203Pb]VMT01 for single photon emission computed tomography (SPECT) and [68Ga]VMT02 for positron emission tomography (PET) imaging of stage 4 melanoma2R44CA203430-02A1 · under PA-18-573 | JOHNSON, FRANCES L | VIEWPOINT MOLECULAR TARGETING, INC., IA | $958,108 | ZRG1 |
| 2019 | Wearable technology to reduce risk of DVT and increase patient compliance2R44HL132624-02 · under PA-18-573 | SCHWEGMAN, JEFFREY | RECOVERY FORCE, LLC, IN | $942,340 | ZRG1 |
| 2019 | A Novel, Low-Cost Device to Guide Peripherally Inserted Central Catheter (PICC) Line Placement2R44AG060793-02 · under PA-18-573 | BURNETT, DANIEL ROGERSSALAMINI, ALEXEY | PICCOLO MEDICAL, INC., CA | $915,143 | ZRG1 |
| 2019 | Feasibility of a mobile parent-based intervention to reduce alcohol use by highschool seniors2R44AA025293-02 · under PA-18-573 | HECHT, MICHAEL | REAL PREVENTION, LLC, NJ | $897,472 | ZRG1 |
| 2019 | A Non-Invasive Neuromodulation Device for In-Home Treatment of Overactive Bladder2R44AG058272-02 · under PA-18-573 | BURNETT, DANIEL ROGERS | THERANOVA, LLC, CA | $806,779 | ZRG1 |
| 2019 | Intelligent and Adaptive Control Applied to Powered Walkers2R44HD082863-02 · under PA-18-573 | BURKHOLDER, JASON O.PARKER, B EUGENE | BARRON ASSOCIATES, INC., VA | $785,810 | ZRG1 |
| 2019 | Automating Peer Learning to Reduce Alcohol Use and Related Deviant Behavior in Secondary School2R44AA027422-02 · under PA-18-573 | SMITH, DAVID RANDOLPHVAN RYZIN, MARK J | OREGON RES BEHAVIORAL INTERVENTION STRAT, OR | $777,096 | ZRG1 |
| 2019 | Mindfulness Mobile App to Reduce Adolescent Substance Use2R44DA043288-02 · under PA-18-573 | SMITH, DANA K | OREGON RES BEHAVIORAL INTERVENTION STRAT, OR | $759,763 | ZRG1 |
| 2019 | Passive Exoskeleton for Children with Neuromuscular Disorders2R44HD089789-02 · under PA-18-573 | LUNDSTROM, JULIE | RUSH RIVER RESEARCH CORPORATION, WI | $743,529 | ZRG1 |
| 2019 | ARTERY Outcomes: tAilored dRug Titration through artificial intElligence: an inteRventional studY1R44HL149428-01 · under PA-18-573 | VOSKERICIAN, GABRIELA | OPTIMA INTEGRATED HEALTH, INC., CA | $739,992 | ZRG1 |
| 2019 | Culturally Responsive Stress Reduction: A Mobile Mindfulness Application toSupport Health Promotion for African Americans2R44MD012284-02 · under PA-18-573 | TRUSTY, TERESSAWATSON-SINGLETON, NATALIE NWENDT, ADAM JOHN | IRIS MEDIA, INC., OR | $735,507 | ZRG1 |
| 2019 | Reducing HIV Health Disparities among African American Transgender Women: An mHealth Approach to Improving Prevention, Testing, and Treatment Outcomes2R44MH117837-02 · under PA-18-573 | LEAF, SAMANTHA L. | ISA ASSOCIATES, INC., VA | $681,047 | ZRG1 |
| 2019 | Improving Repair of Female Congenital and Reproductive Anomalies2R44HD092156-02 · under PA-18-573 | GOWDA, ASHOK | BIOTEX, INC., TX | $672,211 | ZRG1 |
| 2019 | 3D Holographic Guidance, Navigation, and Control (3D GN&C) for Endovascular Aortic Repair (EVAR)2R44HL139290-02 · under PA-18-573 | GOEL, VIKASHWEST, KARL | CENTERLINE BIOMEDICAL, INC., OH | $666,977 | ZRG1 |
| 2019 | Pointdexter: A Prosthetic Fingertip Terminal Device2R44HD090800-02A1 · under PA-18-573 | FARRELL, TODD RICHARD | LIBERATING TECHNOLOGIES, INC., MA | $645,076 | ZRG1 |
| 2019 | Improving Neurological Health in Aging via Neuroplasticity-based Computerized Exercise (INHANCE)2R44AG039965-05 · under PA-18-573 | ATTARHA, MOUNAVANVLEET, THOMAS | POSIT SCIENCE CORPORATION, CA | $576,240 | ZRG1 |
| 2019 | A Next Generation, Low Cost Tracking System for Healthcare Process Validation (2)2R44NR015928-02A1 · under PA-18-573 | SCHANTZ, HANS GREGORY | GAN CORPORATION, AL | $565,135 | ZRG1 |
| 2019 | Speech Perception Training: Advanced Scoring and Feedback Methods2R44DC015418-02 · under PA-18-573 | EBERHARDT, SILVIO P | SEEHEAR, LLC, VA | $549,543 | ZRG1 |
| 2019 | BurntOut: Role-Play Simulation for Building Medical Student Resiliency2R44AA026474-02 · under PA-18-573 | TANNER, BRADLEY | CLINICAL TOOLS, INC., NC | $501,261 | ZRG1 |
| 2019 | LEVERAGING PREDICTIVE ANALYTICS WITHIN SOCIAL NETWORKS TO MAXIMIZE DRUG ANDALCOHOL TREATMENT EFFICACY AND RELAPSE PREVENTION2R44DA044062-02 · under PA-18-573 | PESCE, CHRISTOPHER NEIL | SOBER GRID, INC., OH | $499,907 | ZRG1 |
| 2019 | Fall Detection and Prevention for Memory Care through Real-Time Artificial Intelligence Applied to Video2R44AG058354-02A1 · under PA-18-573 | XIONG, GLEN | SAFELYYOU, INC., CA | $493,633 | ZRG1 |
| 2019 | First and Only Soft Tissue Support Device to Improve Patient Experience and System Cost in Breast Reconstruction1R44CA247273-01 · under PA-18-573 | KIM, JOHN YMLODINOW, ALEXEI | SURGICAL INNOVATION ASSOCIATES, INC., IL | $466,972 | ZRG1 |
| 2019 | Goldmann Contact Tonometry with Optimized Error Correction2R44EY026821-02A1 · under PA-18-573 | MCCAFFERTY, SEAN J | CATS TONOMETER, LLC, AZ | $428,670 | ZRG1 |
| 2019 | Non-intrusive detection of temporary neurologic impairment by opioids1R43DA049684-01 · under PA-18-573 | BESSERMAN, RICHARD | ZXEREX CORPORATION, AZ | $349,933 | ZRG1 |
| 2019 | Home-based Virtual Reality System for the Treatment of Chemotherapy-related Cognitive Impairments1R43CA232936-01A1 · under PA-18-573 | BURDEA, GRIGORE C | BRIGHT CLOUD INTERNATIONAL CORPORATION, FL | $300,000 | ZRG1 |
| 2019 | Multimodal Optical Probe for Skin Cancer Detection and Therapy Guidance1R44CA240040-01A1 · under PA-18-573 | IFTIMIA, NICUSOR | PHYSICAL SCIENCES, INC, MA | $300,000 | ZRG1 |
| 2019 | Precision Gait Retraining for Children with Cerebral Palsy1R43HD100209-01 · under PA-18-573 | CONTESSA, PAOLA | ALTEC, INC., MA | $295,297 | ZRG1 |
| 2019 | Expert Guiding Technology to Help Individuals with Developmental Challenges Build Life and Vocational Skills1R43MH121230-01 · under PA-18-573 | NOSEK, JOHN | GUIDING TECHNOLOGIES CORPORATION, PA | $282,159 | ZRG1 |
| 2019 | Trauma-Informed Mental Health in Education: A Mindfulness Based Curriculum (TimeIn)1R44HD098921-01 · under PA-18-573 | KELLY, NICHOLE RHEAPENNEFATHER, JORDANWENDT, ADAM JOHN | IRIS MEDIA, INC., OR | $260,679 | ZRG1 |
| 2019 | Smartphone-Based Intervention for Sleep Disturbance in Individuals Recovering from Alcohol Use Disorder1R44AA028164-01 · under PA-18-573 | FRANK, ELLEN | HEALTH RHYTHMS, INC., NY | $250,572 | ZRG1 |
| 2019 | Wiring Adolescents With Social Anxiety via Behavioral Interventions (WASABI): a closed-loop mobile intervention to reduce social anxiety and improve social skills1R43MH121209-01 · under PA-18-573 | BIAGIANTI, BRUNO | POSIT SCIENCE CORPORATION, CA | $243,975 | ZRG1 |
| 2019 | Online system for identifying and addressing teen depression in primary care1R44MH116751-01A1 · under PA-18-573 | HOWARD, BARBARA JOSTURNER, RAYMONDWAMBOLDT, MARIANNE ZDEBLICK | TOTAL CHILD HEALTH, INC., MD | $242,854 | ZRG1 |
| 2019 | FitMi Plus: Smart Functional Modules for Practicing Activities of Daily Living after Stroke1R44HD097803-01 · under PA-18-573 | ZONDERVAN, DANIEL | FLINT REHABILITATION DEVICES, CA | $225,001 | ZRG1 |
| 2019 | Non-invasive cloud connected device for hemodynamic-guided therapy toimprove outcomes for heart failure patients1R44HL145941-01A1 · under PA-18-573 | KALE, KAUSTUBH | AVENTUSOFT, LLC, FL | $225,001 | ZRG1 |
Showing the 200 most recent of 231 awards.
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.